Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Insulin Resistance 1 Hypoglycemia 1 Fatigue 1 Cachexia 1

Interventions

Metformin 30 Exercise 8 Pioglitazone 7 Inositol 6 Insulin 4 Acupuncture Therapy 4 High-Intensity Interval Training 3 Ethinyl Estradiol 3 salicylsalicylic acid 2 drospirenone and ethinyl estradiol combination 2 Water 2 Tablets 2 Sugars 2 Resistance Training 2 Preoperative Exercise 2 Folic Acid 2 Diet Therapy 2 Cyproterone Acetate 2 Caloric Restriction 2 Biguanides 2 ziprasidone 1 maltodextrin 1 lime 1 licogliflozin 1 exendin (9-39) 1 drospirenone 1 cinnulin PF 1 adrenosterone 1 Zoledronic Acid 1 World Health Organization oral rehydration solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Insulin Resistance × Flour × Clear all

NCT00970541 2021-08-25

Eccentric

Pennington Biomedical Research Center

Phase 1 Terminated

Hypoglycemia, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡